Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fabry's disease: a multidisciplinary disorder

F P Peters1, A Sommer, A Vermeulen

  • 1Department of Internal Medicine, University Hospital Maastricht, The Netherlands.

Postgraduate Medical Journal
|March 31, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case of cutis verticis gyrata, induced by misuse of anabolic substances?

Clinical and experimental dermatology·2005
Same author

Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society·2005
Same author

Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.

The Journal of steroid biochemistry and molecular biology·2005
Same author

[Extensive, painful erosion of the vulva. Extramammary Paget disease].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2005
Same author

Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours.

European journal of cancer (Oxford, England : 1990)·2004
Same author

In vivo models for endocrine-dependent breast carcinomas: special considerations of clinical relevance.

European journal of cancer (Oxford, England : 1990)·2004
Same journal

Dapagliflozin-induced anaphylactic shock.

Postgraduate medical journal·2026
Same journal

Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

Postgraduate medical journal·2026
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
Same journal

Response to traumatic injuries in polo players in England.

Postgraduate medical journal·2026
See all related articles

Fabry disease, an X-linked disorder, stems from alpha-galactosidase A deficiency, causing glycolipid buildup. Early diagnosis via biopsy, enzyme activity, and genetic tests is crucial for managing symptoms.

Area of Science:

  • Genetics
  • Biochemistry
  • Rare Diseases

Background:

  • Fabry disease is an X-linked inherited condition.
  • It is characterized by the deficiency of the enzyme alpha-galactosidase A.
  • This deficiency leads to the accumulation of a specific glycolipid (galactosylgalactosyl glucosylceramide) within cells.

Observation:

  • Diagnosis relies on a combination of methods.
  • These include histopathologic examination of skin biopsy samples.
  • Assessing alpha-galactosidase A activity in leukocytes and genetic testing are also key diagnostic tools.

Findings:

  • The study highlights the importance of early and accurate diagnosis.
  • It emphasizes that current treatment for Fabry disease is primarily symptomatic.

Related Experiment Videos

  • The core finding is the necessity of a multidisciplinary approach.
  • Implications:

    • Early diagnosis and intervention can help prevent symptom acceleration.
    • A collaborative, multidisciplinary team is essential for comprehensive patient care.
    • This approach ensures better management of Fabry disease progression.